Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
319 hedge funds and large institutions have $4.41B invested in Exact Sciences in 2018 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 113 increasing their positions, 95 reducing their positions, and 56 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 95
7.67% more ownership
Funds ownership: 82.87% → 90.54% (+7.7%)
5% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 56
0% more funds holding
Funds holding: 318 → 319 (+1)
15% less capital invested
Capital invested by funds: $5.21B → $4.41B (-$799M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
75% less call options, than puts
Call options by funds: $67.8M | Put options by funds: $268M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$142M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$140M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$119M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$72.9M |
| 5 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
+$63.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$101M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
-$50.7M |
| 3 |
Morgan Stanley
New York
|
-$45.8M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$45.2M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$43.7M |
EXAS Hedge Fund Activity: Q1 2018 in Review
319 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2018, worth a combined $4.41B — down 15% from $5.21B a quarter earlier.
Buyers outnumbered sellers: 59 funds opened new EXAS positions and 56 closed out — a net gain of 3 holders — while 113 added to existing stakes and 95 trimmed.
The largest buyer was OppenheimerFunds, adding an estimated $142M. The largest seller was Citigroup, cutting an estimated $101M.
- 319 institutional investors held Exact Sciences (EXAS) as of Q1 2018, up from 318 in Q4 2017.
- Funds reported $4.41B of Exact Sciences stock for Q1 2018, down 15% quarter-over-quarter.
- 59 funds opened new Exact Sciences positions in Q1 2018 and 56 closed out, a net change of +3 holders.
- The largest Exact Sciences buyer in Q1 2018 was OppenheimerFunds, an estimated $142M added.
- The largest Exact Sciences seller in Q1 2018 was Citigroup, an estimated $101M sold.
Based on aggregated 13F filings for Q1 2018.